Cargando…
Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease
BACKGROUND: Deterioration of cognitive functioning is a debilitating symptom in many neurodegenerative diseases, such as Huntington's disease (HD). To date, there are no effective treatments for the cognitive problems associated with HD. Cognitive assessment outcomes will have a central role in...
Autores principales: | Stout, Julie C, Jones, Rebecca, Labuschagne, Izelle, O'Regan, Alison M, Say, Miranda J, Dumas, Eve M, Queller, Sarah, Justo, Damian, Santos, Rachelle Dar, Coleman, Allison, Hart, Ellen P, Dürr, Alexandra, Leavitt, Blair R, Roos, Raymund A, Langbehn, Doug R, Tabrizi, Sarah J, Frost, Chris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368487/ https://www.ncbi.nlm.nih.gov/pubmed/22566599 http://dx.doi.org/10.1136/jnnp-2011-301940 |
Ejemplares similares
-
Structural and functional brain network correlates of depressive symptoms in premanifest Huntington's disease
por: McColgan, Peter, et al.
Publicado: (2017) -
Testing a longitudinal compensation model in premanifest Huntington’s disease
por: Gregory, Sarah, et al.
Publicado: (2018) -
White matter predicts functional connectivity in premanifest Huntington's disease
por: McColgan, Peter, et al.
Publicado: (2017) -
Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington’s disease
por: McColgan, Peter, et al.
Publicado: (2017) -
In vivo characterization of white matter pathology in premanifest huntington's disease
por: Zhang, Jiaying, et al.
Publicado: (2018)